JULUCA
Identification of Juluca
| No description |
Google image searchProduct monograph
Active ingredients
dolutegravir (dolutegravir sodium), 50 MG
rilpivirine (rilpivirine hydrochloride), 25 MG
DIN: 02475774
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 04-JUN-2018
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR21 — DOLUTEGRAVIR AND RILPIVIRINE (ATC/DDD)
Reference brand drug: Juluca
